AQP1 and systemic inflammatory response syndrome: A particularly clear and streamlined outcome was obtained in experiments in which highly pure splenic polyclonal, na?ve CD4+/CD8+ T-cell preparations were challenged ex vivo with a panel of TCR/co-receptor antibody combinations that had been devised to sample for any irregularities in the T-cell response after SIRS/sepsis.